Entia Liberty: Home Study

NCT05462288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2024-03-13

No results posted yet for this study

Summary

Participants will be testing with the home monitoring device over the course of their treatment. They are to self-test on days where they are due to be going into hospital for their routine pre-treatment blood tests. Participants will be asked to fill in interim questionnaires and a final questionnaire to answer the study objectives.

Conditions

Interventions

DEVICE

Entia Liberty

Home monitoring blood analyser

Sponsors & Collaborators

  • Entia Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-06
Primary Completion
2023-12-05
Completion
2023-12-05

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462288 on ClinicalTrials.gov